...
首页> 外文期刊>Washington Drug Letter >HHS Awards Drugmakers Anti-Bioterrorism Contracts
【24h】

HHS Awards Drugmakers Anti-Bioterrorism Contracts

机译:HHS授予药品制造商反生物恐怖主义合同

获取原文
获取原文并翻译 | 示例
           

摘要

Four companies were awarded contracts totaling $55.3 million for the development of anthrax antitoxins, therapeutics and antibiotics to treat plague and tularemia, HHS announced.rnTularemia is an illness caused by exposure to bacterium Francisella tularensis. If weaponized into aerosol form, the agent can cause severe respiratory illness and is life-threatening if left untreated, according to the Centers for Disease Control and Prevention.
机译:HHS宣布,四家公司获得了总额为5530万美元的合同,用于开发炭疽抗毒素,治疗鼠疫和Tularemia的抗生素和抗生素。根据疾病控制和预防中心的说法,如果将这种药物配制成气雾剂,会导致严重的呼吸道疾病,如果不加以治疗,将会危及生命。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号